These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30833076)

  • 1. Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
    Lu L; Huang W; Hu W; Jiang L; Li Y; Wu X; Yuan D; Li M
    Biochem Biophys Res Commun; 2019 Apr; 511(4):772-779. PubMed ID: 30833076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53-survivin signaling cascade.
    Chang HL; Chen CY; Hsu YF; Kuo WS; Ou G; Chiu PT; Huang YH; Hsu MJ
    Biochim Biophys Acta; 2013 Aug; 1830(8):4053-64. PubMed ID: 23583370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
    Pereira M; Glogova A; Haagsma J; Stewart J; Shepherd TG; Petrik J
    J Ovarian Res; 2023 Nov; 16(1):218. PubMed ID: 37986175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice.
    Cho SJ; Kim JS; Kim JM; Lee JY; Jung HC; Song IS
    Int J Cancer; 2008 Aug; 123(4):951-7. PubMed ID: 18521906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin suppresses the proangiogenic microenvironment of human hepatic stellate cells via the Kruppel-like factor 2 pathway.
    Miao Q; Zeng X; Ma G; Li N; Liu Y; Luo T; Lian J; Chen S
    Rev Esp Enferm Dig; 2015 Feb; 107(2):63-71. PubMed ID: 25659387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells.
    Halaschek-Wiener J; Wacheck V; Schlagbauer-Wadl H; Wolff K; Kloog Y; Jansen B
    Mol Med; 2000 Aug; 6(8):693-704. PubMed ID: 11055588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c.
    Ghavami S; Mutawe MM; Hauff K; Stelmack GL; Schaafsma D; Sharma P; McNeill KD; Hynes TS; Kung SK; Unruh H; Klonisch T; Hatch GM; Los M; Halayko AJ
    Biochim Biophys Acta; 2010 Apr; 1803(4):452-67. PubMed ID: 20045437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress.
    Rossi J; Rouleau L; Tardif JC; Leask RL
    Life Sci; 2010 Jul; 87(3-4):92-9. PubMed ID: 20493886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells.
    Perletti G; Marras E; Dondi D; Osti D; Congiu T; Ferrarese R; de Eguileor M; Tashjian AH
    Int J Cancer; 2005 Jan; 113(1):42-53. PubMed ID: 15386430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
    Al-Haidari AA; Syk I; Thorlacius H
    Biochem Biophys Res Commun; 2014 Mar; 446(1):68-72. PubMed ID: 24582560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity.
    Turrell FK; Kerr EM; Gao M; Thorpe H; Doherty GJ; Cridge J; Shorthouse D; Speed A; Samarajiwa S; Hall BA; Griffiths M; Martins CP
    Genes Dev; 2017 Jul; 31(13):1339-1353. PubMed ID: 28790158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin enhances the radiosensitivity of p53‑deficient cells via inhibition of mouse double minute 2 homolog.
    Lee JY; Kim MS; Ju JE; Lee MS; Chung N; Jeong YK
    Int J Oncol; 2018 Jan; 52(1):211-218. PubMed ID: 29115437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.
    Stine JE; Guo H; Sheng X; Han X; Schointuch MN; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2016 Jan; 7(1):946-60. PubMed ID: 26503475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
    Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
    Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA‑192 acts as a tumor suppressor in colon cancer and simvastatin activates miR‑192 to inhibit cancer cell growth.
    Zheng XF; Liu KX; Wang XM; Zhang R; Li X
    Mol Med Rep; 2019 Mar; 19(3):1753-1760. PubMed ID: 30628692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2.
    Tuomisto TT; Lumivuori H; Kansanen E; Häkkinen SK; Turunen MP; van Thienen JV; Horrevoets AJ; Levonen AL; Ylä-Herttuala S
    Cardiovasc Res; 2008 Apr; 78(1):175-84. PubMed ID: 18192240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.
    Freed-Pastor WA; Mizuno H; Zhao X; Langerød A; Moon SH; Rodriguez-Barrueco R; Barsotti A; Chicas A; Li W; Polotskaia A; Bissell MJ; Osborne TF; Tian B; Lowe SW; Silva JM; Børresen-Dale AL; Levine AJ; Bargonetti J; Prives C
    Cell; 2012 Jan; 148(1-2):244-58. PubMed ID: 22265415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
    Roger L; Jullien L; Gire V; Roux P
    J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.
    Mandal CC; Ghosh-Choudhury N; Yoneda T; Choudhury GG; Ghosh-Choudhury N
    J Biol Chem; 2011 Apr; 286(13):11314-27. PubMed ID: 21199873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins.
    Marrone G; Russo L; Rosado E; Hide D; García-Cardeña G; García-Pagán JC; Bosch J; Gracia-Sancho J
    J Hepatol; 2013 Jan; 58(1):98-103. PubMed ID: 22989565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.